Juan A. Reyna, MD, who has served as president and CEO of Urology San Antonio for 16 years, has stepped down as the leader of the 29-physician group. He will continue to work as a urologist at the medical practice.
Juan A. Reyna, MD, who has served as president and CEO of Urology San Antonio for 16 years, has stepped down as the leader of the 29-physician group. He will continue to work as a urologist at the medical practice.
Clayton H. Hudnall, MD, Urology San Antonio’s vice president, will serve as interim president and CEO until the group selects a new physician leader next year, the practice said in a statement.
"It has been a privilege to serve with so many wonderful people. I’m proud of what we’ve accomplished together over the years, growing Urology San Antonio into an organization that other groups study as a model," Dr. Reyna said. "This has been a difficult decision, but I’m looking forward to exploring new challenges and opportunities."
Dr. Reyna completed his residency at the University of Texas Health Science Center at San Antonio in 1981. In July that year, he opened his practice as a solo urologist in downtown San Antonio. By 1996, the practice had grown to seven urologists. That year, it merged with another local urology group to form Urology San Antonio.
Dr. Reyna has served as the president and CEO of the group since its founding. Today, the practice includes 28 urologists, a radiation oncologist, nine clinic locations, and approximately 200 employees.
Dr. Reyna is also president-elect of the Large Urology Group Practice Association.
Malpractice Consult: How likely are you to face a medical malpractice lawsuit?
July 23rd 2024"Although there is a good chance that you will face allegations of medical negligence at some point in your career, it is unlikely that you will ever be found liable by a jury," writes Victoria L. Neikam, Esq.
UK study of AI-based software for prostate cancer detection expands
July 22nd 2024"We will be looking not only at how well this software performs in a busy clinical setting and whether diagnostic accuracy and efficiency improves, but also assessing the experience of clinicians and patients, and looking at the impact on workflow," says Clare Verrill, BM, FRCPath, MMedEd.